Methylprednisolone Doesn't Enhance Opioids' Analgesic Effect on Cancer Pain

Share this content:
Methylprednisolone Doesn't Enhance Opioids' Analgesic Effect on Cancer Pain
Methylprednisolone Doesn't Enhance Opioids' Analgesic Effect on Cancer Pain

(HealthDay News) -- The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online in the Journal of Clinical Oncology.

Ørnulf Paulsen, MD, of the Telemark Hospital Trust in Skien, Norway, and colleagues randomly assigned 50 adult patients receiving opioids for cancer pain to either corticosteroid therapy with MP or placebo (PL).

RELATED: Supportive Care Resource Center

At day 7, the researchers observed no difference between the groups in pain intensity (MP, 3.60 vs. PL, 3.68; P = 0.88) or relative analgesic consumption (MP, 1.19 vs. PL, 1.20; P = 0.95). Patients receiving MP, compared with those receiving PL, experienced reduced fatigue (−17 vs. 3 points; P = 0.003), decreased appetite loss (−24 vs. 2 points; P = 0.003), and increased patient satisfaction (5.4 vs. 2.0 points; P = 0.001).

No differences in adverse effects were observed between the groups.

"MP 32 mg daily did not provide additional analgesia in patients with cancer receiving opioids, but it improved fatigue, appetite loss, and patient satisfaction," the researchers wrote. "Clinical benefit beyond a short-term effect must be examined in a future study."


  1. Paulsen Ø, Klepstad P, Rosland JH, et al. Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial. J Clin Oncol. 2014;doi:10.1200/JCO.2013.54.3926.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs